CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Series A and B Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]	Capital Deficiency [Member]	Accumulated Deficit [Member]	Total
Balance at the beginning at Dec. 31, 2019	$ 150	$ 500	$ 1,996	$ 3,350,120	$ (3,520,320)	$ (167,554)
Balance at the beginning (in shares) at Dec. 31, 2019	150,000	500,000	1,996,355
Increase Decrease In Stockholders Equity [Roll Forward]
Shares issued for services - Series B Preferred	$ 650			43,829		44,479
Shares issued for services - Series B Preferred (in shares)	650,000
Conversion of Series B Preferred stock to Common stock	$ (650)		$ 650,000	$ (649,350)
Conversion of Series B Preferred stock to Common stock (in shares)	(650,000)		650,000,000
Effect of Share exchange and reverse merger			$ 100	$ (3,520,420)	$ 3,451,328	(68,992)
Effect of Share exchange and reverse merger (in shares)			100,000
Net loss					$ (2,500)	(2,500)
Balance at the end at Mar. 31, 2020	$ 150	$ 500	$ 652,096	(775,821)	(71,492)	(194,567)
Balance at the end (in shares) at Mar. 31, 2020	150,000	500,000	652,096,355
Balance at the beginning at Dec. 31, 2020	$ 650	$ 500	$ 652,096	(475,243)	(441,735)	(263,712)
Balance at the beginning (in shares) at Dec. 31, 2020	650,000	500,000	652,096,355
Increase Decrease In Stockholders Equity [Roll Forward]
Net loss					(26,514)	(26,514)
Balance at the end at Mar. 31, 2021	$ 670	$ 500	$ 652,096	$ (475,243)	$ (468,249)	$ (290,226)
Balance at the end (in shares) at Mar. 31, 2021	670,000	500,000	652,096,355